PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicaid · Prior Auth · Pharmacy · LA · PharmacyHigh impact

Drug Utilization Management and Clinical Edits Tools (New)

Effective date
Oct 1, 2025
Identified
Sep 23, 2026

Summary

This new Humana Medicaid-Louisiana pharmacy policy (effective October 1, 2025) establishes Drug Utilization Management (DUM) and clinical editing tools including prior authorization, step therapy, quantity limits, accumulation edits, duplication edits, and drug/age/gender/disease/drug-drug/pregnancy edits. The policy applies clinical edits at point-of-service for safety and cost-effectiveness, with grandfathering provisions for specific drug classes (antidepressants, antipsychotics, anticonvulsants, antineoplastics, antiretrovirals, and immunosuppressants). Billing teams must prepare for increased pharmacy claim rejections and prior authorization requirements.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

Action · 10 steps
01REQUIREMENTS: By October 1, 2025: Billing and pharmacy teams must: 1.
02Update billing system configuration to implement electronic clinical edits at point-of-service for all pharmacy claims on Louisiana Medicaid plans, including: prior authorization requirements, step therapy protocols, quantity limits, accumulation edits, duplication edits, and drug/age/gender/disease/drug-drug/pregnancy edits 2.
03Establish prior authorization workflow procedures for non-grandfathered medications and communicate to prescribers 3.
04Train front-desk and billing staff to communicate to patients that certain pharmacy claims may require prior authorization before dispensing 4.
05Document which drug classes are grandfathered (currently: antidepressants for behavioral health, antipsychotics, anticonvulsants for epilepsy, antineoplastics, antiretrovirals, immunosuppressants for transplant prophylaxis) and ensure these receive expedited approval 5.
06Implement appeals process for members stable on therapy using diagnosis, coverage limitations, disease progression, and ECOG criteria 6.
07Flag drug samples as NOT qualifying as treatment experience for step therapy/PA requirements—prior sample use does not waive new-start restrictions 7.
08Update claim submission procedures to include required medical records for appeals Consequences: Claims will be denied at point-of-service without proper prior authorization or step therapy completion.
09Members may experience pharmacy delays.
10Non-compliance will result in increased claim denials and member complaints.

Original notice

Drug Utilization Management and Clinical Edits Tools (New)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account